Targeted inhibition of the H3K27ac/OGT/O-GlcNAcylation axis to overcome gemcitabine-induced chemotherapy resistance in bladder cancer
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 2026-08 · 1872 (6) · 168281
DOI: 10.1016/j.bbadis.2026.168281 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2026-08. Verfasst von Zhijuan Liang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Urology and Andrology, Department of Medical Research Center, The Affiliated Hospital of Qingdao University, Qingdao, 266003, China. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Deoxycytidine, N-Acetylglucosaminyltransferases, Drug Resistance, Neoplasm. Die Arbeit nennt 65 Literaturangaben. Gefördert von: Natural Science Foundation of Qingdao, Qingdao University, Medical and Health Science and Technology Development Project of Shandong Province.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Gemcitabine (Gem), a primary treatment for advanced and metastatic bladder cancer, can lead to malignant progression and drug resistance, though the underlying mechanisms are not fully understood. Post-translational modifications (PTMs) are key to understanding this resistance and identifying new chemosensitizers. To decipher the relationship between the PTM and Gem-induced chemotherapy resistance in bladder cancer, a Gem-resistant cell line was developed from Gem-sensitive cells through repeated exposure to the drug, revealing increased levels of acetylation and O-GlcNAcylation compared to the parent cells. Thereafter, considering the significant role of histone acetylation in gene regulation, the histone acetyltransferase inhibitor C646 was employed to inhibit growth of Gem-resistant bladder cancer cells. Intriguingly, C646 was found to prevent the progression of Gem-resistant bladder cancer not only by inhibiting acetylation but also O-GlcNAcylation modifications both in vitro and in vivo. Immunohistochemistry analysis of bladder cancer clinical specimens confirmed that both histone H3 lysine 27 acetylation (H3K27ac) and O-GlcNAc transferase (OGT) expression levels were elevated post-chemotherapy and positively correlated. Further, chromatin immunoprecipitation followed by quantitative reverse transcription polymerase chain reaction (ChIP-qPCR) demonstrated that H3K27ac influences OGT expression by binding to its promoter region. Additionally, C646 disrupted OGT-mediated O-GlcNAcylation by suppressing the acetylation of H3K27 and its accumulation on the OGT promoter, thereby inhibiting Gem-resistant bladder cancer growth. Consequently, targeting the H3K27ac/OGT axis with histone acetyltransferase inhibitor offers a promising strategy to overcome Gem resistance in bladder cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Urology and Andrology, Department of Medical Research Center, The Affiliated Hospital of Qingdao University, Qingdao, 266003, China.
- Department of Urology, The Affiliated Hospital of Qingdao University, Qingdao, 266003, China.
- Key Laboratory of Urology and Andrology, Department of Medical Research Center, The Affiliated Hospital of Qingdao University, Qingdao, 266003, China. Electronic address: liangye82812@163.com.
Förderung
- Natural Science Foundation of Qingdao
- Qingdao University
- Medical and Health Science and Technology Development Project of Shandong Province
- Shandong Province Natural Science Foundation
Zitieren
APA
Liang, Z., Wang, L., Li, D., Chen, Y., Tian, X., Yuan, Y., Chu, G., & Liang, Y. (2026). Targeted inhibition of the H3K27ac/OGT/O-GlcNAcylation axis to overcome gemcitabine-induced chemotherapy resistance in bladder cancer. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1872(6), 168281. https://doi.org/10.1016/j.bbadis.2026.168281
Vancouver
Liang Z, Wang L, Li D, Chen Y, Tian X, Yuan Y, et al. Targeted inhibition of the H3K27ac/OGT/O-GlcNAcylation axis to overcome gemcitabine-induced chemotherapy resistance in bladder cancer. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2026;1872(6):168281. doi:10.1016/j.bbadis.2026.168281
BibTeX
@article{Liang2026,
author = {Liang, Zhijuan and Wang, Liping and Li, Dan and Chen, Yuanbin and Tian, Xintao and Yuan, Yi and Chu, Guangdi and Liang, Ye},
title = {Targeted inhibition of the H3K27ac/OGT/O-GlcNAcylation axis to overcome gemcitabine-induced chemotherapy resistance in bladder cancer},
journal = {Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease},
year = {2026},
volume = {1872},
number = {6},
pages = {168281},
doi = {10.1016/j.bbadis.2026.168281}
}
EUVIMED